Related Articles
Prognostic markers in clinically localised prostate cancer.
No residual tumor in a radical prostatectomy specimen after neoadjuvant hormonal therapy for localized prostate cancer
Evaluation of HOXB13 as a molecular marker of recurrent prostate cancer
Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression
CXC chemokine mRNA expression as a potential diagnostic tool in prostate cancer